7.11
-0.06(-0.84%)
Currency In USD
| Previous Close | 7.17 |
| Open | 7.19 |
| Day High | 7.24 |
| Day Low | 7.05 |
| 52-Week High | 10.79 |
| 52-Week Low | 4.54 |
| Volume | 252,475 |
| Average Volume | 333,880 |
| Market Cap | 449.16M |
| PE | -9 |
| EPS | -0.79 |
| Moving Average 50 Days | 6.33 |
| Moving Average 200 Days | 7.4 |
| Change | -0.06 |
If you invested $1000 in Treace Medical Concepts, Inc. (TMCI) since IPO date, it would be worth $279.67 as of September 08, 2025 at a share price of $7.14. Whereas If you bought $1000 worth of Treace Medical Concepts, Inc. (TMCI) shares 3 years ago, it would be worth $329.03 as of September 08, 2025 at a share price of $7.14.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Treace Medical to Host Investor Day Highlighting New Products on September 3, 2025
GlobeNewswire Inc.
Aug 07, 2025 8:01 PM GMT
PONTE VEDRA, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defor
Treace Announces Peer-Reviewed Publication of Four-Year Results of the ALIGN3D™ Lapiplasty® Multicenter Prospective Clinical Study
GlobeNewswire Inc.
Aug 05, 2025 8:05 PM GMT
PONTE VEDRA, Fla., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defor
Treace to Report Second Quarter 2025 Financial Results on August 7, 2025
GlobeNewswire Inc.
Jul 24, 2025 8:05 PM GMT
PONTE VEDRA, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defor